Top

Administration and Policy in Mental Health and Mental Health Services Research

Published in:

01-09-2021 | Schizophrenia | Original Article

Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?

Authors: Warut Aunjitsakul, Teerapat Teetharatkul, Arnont Vitayanont, Tippawan Liabsuetrakul

Published in: Administration and Policy in Mental Health and Mental Health Services Research | Issue 5/2021

Abstract

To examine the agreement between patient and psychiatrist ratings of subjective well-being in people with schizophrenia using three well-being measurements: Satisfaction with Life, Subjective Happiness, and Subjective Well-being under Neuroleptic Treatment (SWN), including the SWN-subscale, and to investigate whether the psychiatrist’s judgement or the psychiatrist-rated SWN is better at defining patient well-being. Patients with schizophrenia (n = 150) completed the three well-being measurements, then met psychiatrists, and their well-being was judged as either ‘poor’ or ‘adequate’ via the usual clinical assessment before being assessed again by the psychiatrist using the same measurements. Intra-class correlation was used to analyze the absolute agreement between ‘patient-rated’ and ‘psychiatrist-rated’ scores. Agreements on ‘adequate’ well-being status between patient-rated SWN (≥ 80; gold standard), psychiatrist-rated SWN, and psychiatrist’s judgement were calculated using Kappa coefficients. We also calculated the sensitivity and specificity of the psychiatrist’s judgement and the psychiatrist-rated SWN to define adequate well-being. SWN showed the strongest absolute agreement between patient-psychiatrist ratings (ICC = 0.7, p = 0.005), with physical functioning yielding the highest and self-control the lowest coefficients. The psychiatrist-rated SWN showed a better Kappa coefficient (0.4, p < 0.001) than the psychiatrist’s judgement. Clinical judgement showed a 67% sensitivity and a 64% specificity, whereas the psychiatrist-rated SWN (score 93, AUC 81.4%) showed a 74% sensitivity and a 74% specificity for well-being prediction. The use of SWN by psychiatrists yielded a better alignment of well-being than the psychiatrist’s judgement alone. The SWN subscale could help fill the gap between clinician and patient views on well-being. Psychiatrists should upskill in assessing patient wellbeing for appropriate treatment provision.

Available only for authorised users

Acosta, F. J., Hernandez, J. L., Pereira, J., Herrera, J., & Rodriguez, C. J. (2012). Medication adherence in schizophrenia. World Journal of Psychiatry, 2(5), 74–82. https://doi.org/10.5498/wjp.v2.i5.74CrossRefPubMedPubMedCentral

Agid, O., McDonald, K., Siu, C., Tsoutsoulas, C., Wass, C., Zipursky, R. B.,…Remington, G. (2012). Happiness in first-episode schizophrenia. Schizophrenia research, 141(1), 98–103.https://doi.org/10.1016/j.schres.2012.07.012

Aunjitsakul, W., & Pitanupong, J. (2018). Schizophrenias’ quality of life and emotional intelligence in Songklanagarind Hospital. Journal of Health Science and Medical Research, 36(1), 61–71.

Aunjitsakul, W., Teetharatkul, T., Vitayanont, A., & Liabsuetrakul, T. (2019). Correlations between self-reported and psychiatrist assessments of well-being among patients with schizophrenia. General Hospital Psychiatry, 56, 52–53. https://doi.org/10.1016/j.genhosppsych.2018.11.001CrossRefPubMed

Chue, P. (2006). The relationship between patient satisfaction and treatment outcomes in schizophrenia. Journal of Psychopharmacology, 20(6 Suppl), 38–56. https://doi.org/10.1177/1359786806071246CrossRefPubMed

de Haan, L., Weisfelt, M., Dingemans, P. M., Linszen, D. H., & Wouters, L. (2002). Psychometric properties of the subjective well-being under neuroleptics scale and the subjective deficit syndrome scale. Psychopharmacology (Berl), 162(1), 24–28. https://doi.org/10.1007/s00213-002-1054-xCrossRef

Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life scale. Journal of Personality Assessment, 49(1), 71–75. https://doi.org/10.1207/s15327752jpa4901_13CrossRef

Diener, E., Suh, E. M., Lucas, R. E., & Smith, H. L. (1999). Subjective well-being: Three decades of progress. Psychological Bulletin, 125(2), 276–302.CrossRef

Eack, S. M., & Newhill, C. E. (2007). Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 33(5), 1225–1237. https://doi.org/10.1093/schbul/sbl071CrossRefPubMedPubMedCentral

Fervaha, G., Agid, O., Takeuchi, H., Foussias, G., & Remington, G. (2016). Life satisfaction and happiness among young adults with schizophrenia. Psychiatry Research, 242, 174–179. https://doi.org/10.1016/j.psychres.2016.05.046CrossRefPubMed

Frosch, D. L., May, S. G., Rendle, K. A., Tietbohl, C., & Elwyn, G. (2012). Authoritarian physicians and patients’ fear of being labeled ‘difficult’ among key obstacles to shared decision making. Health Affairs (Project Hope), 31(5), 1030–1038. https://doi.org/10.1377/hlthaff.2011.0576CrossRef

Gunnmo, P., & Bergman, H. F. (2011). What do individuals with schizophrenia need to increase their well-being. International Journal of Qualitative Studies on Health and Well-Being. https://doi.org/10.3402/qhw.v6i1.5412CrossRefPubMedPubMedCentral

Hallgren, K. A. (2012). Computing inter-rater reliability for observational data: An overview and tutorial. Tutorials in Quantitative Methods for Psychology, 8(1), 23–34. https://doi.org/10.20982/tqmp.08.1.p023CrossRefPubMedPubMedCentral

Hamm, J. A., Buck, K. D., Leonhardt, B. L., Luther, L., & Lysaker, P. H. (2018). Self-directed recovery in schizophrenia: Attending to clients’ agendas in psychotherapy. Journal of Psychotherapy Integration, 28(2), 188–201. https://doi.org/10.1037/int0000070CrossRef

Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granstrom, O., & De Hert, M. (2013). Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Advances in Psychopharmacology, 3(4), 200–218. https://doi.org/10.1177/2045125312474019CrossRefPubMedPubMedCentral

Kahneman, D., & Tversky, A. (1984). Choices, values, and frames. American Psychologist, 39(4), 341–350.CrossRef

Kim-Prieto, C., Diener, E., Tamir, M., Scollon, C., & Diener, M. (2005). Integrating the diverse definitions of happiness: A time-sequential framework of subjective well-being. Journal of Happiness Studies, 6(3), 261–300.CrossRef

Lambert, M., Schimmelmann, B. G., Naber, D., Schacht, A., Karow, A., Wagner, T., & Czekalla, J. (2006). Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. The Journal of Clinical Psychiatry, 67(11), 1690–1697. https://doi.org/10.4088/jcp.v67n1104CrossRefPubMed

Langdon, R., Coltheart, M., Ward, P. B., & Catts, S. V. (2002). Disturbed communication in schizophrenia: The role of poor pragmatics and poor mind-reading. Psychological Medicine, 32(7), 1273–1284.CrossRef

Lehman, A. F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and Program Planning, 11(1), 51–62. https://doi.org/10.1016/0149-7189(88)90033-XCrossRef

Leonhardt, B. L., Huling, K., Hamm, J. A., Roe, D., Hasson-Ohayon, I., McLeod, H. J., & Lysaker, P. H. (2017). Recovery and serious mental illness: A review of current clinical and research paradigms and future directions. Expert Review of Neurotherapeutics, 17(11), 1117–1130. https://doi.org/10.1080/14737175.2017.1378099CrossRefPubMed

Lindstrom, E., Jedenius, E., & Levander, S. (2009). A symptom self-rating scale for schizophrenia (4S): Psychometric properties, reliability and validity. Nordic Journal of Psychiatry, 63(5), 368–374.CrossRef

Lyubomirsky, S., & Lepper, H. S. (1999). A measure of subjective happiness: Preliminary reliability and construct validation. Social Indicators Research, 46(2), 137–155.CrossRef

McHugh, M. L. (2012). Interrater reliability: The kappa statistic. Biochemical Medicine (Zagreb), 22(3), 276–282.CrossRef

Myers, D. G., & Diener, E. (2018). The scientific pursuit of happiness. Perspectives on Psychological Science: A Journal of the Association for Psychological Science, 13(2), 218–225. https://doi.org/10.1177/1745691618765171CrossRefPubMed

Naber, D. (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psychopharmacology, 10(Suppl 3), 133–138.PubMed

Naber, D., Karow, A., & Lambert, M. (2005). Subjective well-being under the neuroleptic treatment and its relevance for compliance. Acta Psychiatrica Scandinavica. Supplementum, 427, 29–34.CrossRef

Naber, D., Moritz, S., Lambert, M., Pajonk, F. G., Holzbach, R., Mass, R., & Andresen, B. (2001). Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophrenia Research, 50(1–2), 79–88.CrossRef

Pavot, W., Diener, E., Colvin, C. R., & Sandvik, E. (1991). Further validation of the satisfaction with life scale: Evidence for the cross-method convergence of well-being measures. Journal of Personality Assessment, 57(1), 149–161. https://doi.org/10.1207/s15327752jpa5701_17CrossRefPubMed

Polit, D. F. (2014). Getting serious about test-retest reliability: A critique of retest research and some recommendations. Quality of Life Research, 23(6), 1713–1720. https://doi.org/10.1007/s11136-014-0632-9CrossRefPubMed

Rettenbacher, M. A., Hofer, A., Eder, U., Hummer, M., Kemmler, G., Weiss, E. M., & Fleischhacker, W. W. (2004). Compliance in schizophrenia: Psychopathology, side effects, and patients’ attitudes toward the illness and medication. Journal of Clinical Psychiatry, 65(9), 1211–1218.CrossRef

Ritsner, M. S., Lisker, A., & Arbitman, M. (2012). Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorders: I. Predictive value of disorder-related factors. Quality of Life Research, 21(5), 837–847. https://doi.org/10.1007/s11136-011-9988-2CrossRefPubMed

Seale, C., Chaplin, R., Lelliott, P., & Quirk, A. (2007). Antipsychotic medication, sedation and mental clouding: An observational study of psychiatric consultations. Social Science & Medicine, 65(4), 698–711. https://doi.org/10.1016/j.socscimed.2007.03.047CrossRef

Strassnig, M., Kotov, R., Fochtmann, L., Kalin, M., Bromet, E. J., & Harvey, P. D. (2018). Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up. Schizophrenia Research, 197, 150–155. https://doi.org/10.1016/j.schres.2018.02.009CrossRefPubMed

Tolman, A. W., & Kurtz, M. M. (2012). Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: A meta-analytic investigation. Schizophrenia Bulletin, 38(2), 304–315. https://doi.org/10.1093/schbul/sbq077CrossRefPubMed

Vothknecht, S., Schoevers, R. A., & de Haan, L. (2011). Subjective well-being in schizophrenia as measured with the subjective well-being under neuroleptic treatment scale: A review. Australian and New Zealand Journal of Psychiatry, 45(3), 182–192. https://doi.org/10.3109/00048674.2010.545984CrossRef

Vothknecht, S., Meijer, C., Zwinderman, A., Kikkert, M., Dekker, J., van Beveren, N.,...For, Group. (2013). Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls. Psychiatry Research, 206(1), 62–67.https://doi.org/10.1016/j.psychres.2012.09.004

Wehmeier, P. M., Kluge, M., Schacht, A., Helsberg, K., & Schreiber, W. (2007). Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Schizophrenia Research, 91(1–3), 178–186. https://doi.org/10.1016/j.schres.2006.12.017CrossRefPubMed

Title: Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?
Authors: Warut Aunjitsakul
Teerapat Teetharatkul
Arnont Vitayanont
Tippawan Liabsuetrakul
Publication date: 01-09-2021
Publisher: Springer US
Keyword: Schizophrenia
Published in: Administration and Policy in Mental Health and Mental Health Services Research / Issue 5/2021
Print ISSN: 0894-587X
Electronic ISSN: 1573-3289
DOI: https://doi.org/10.1007/s10488-021-01127-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

The Organizational Financial Context of Publicly-Funded Mental Health Clinics: Development and Preliminary Psychometric Evaluation of the Agency Financial Status Scales

Correction to: A Systematic Review of Mental Health Interventions for ASD: Characterizing Interventions, Intervention Adaptations, and Implementation Outcomes

Greater Focus on Strengths is Associated with Successful Discharge in Youth Public Mental Health Treatment

A Stakeholder-Engaged Process for Adapting an Evidence-Based Intervention for Posttraumatic Stress Disorder for Peer Delivery

Computerized Adaptive Testing (CAT) and the Future of Measurement-Based Mental Health Care

The Effect of Intensive Implementation Support on Fidelity for Four Evidence-Based Psychosis Treatments: A Cluster Randomized Trial